SCYX - speculative catalyst play
Mis à jour
SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The ibrexafungerp is a novel and structurally distinct triterpenoid glucan synthase inhibitor that is effective in vitro and in vivo against a broad range of Candida and Aspergillus species, including drug-resistant strains as well as Pneumocystis, Coccidioides, Histoplasma and Blastomyces genera and some common mucorales species.
Disclaimer: This is not financial advice.
Upcoming Event: Preclinical Data Release on 04/24/2024
This is a highly speculative investment opportunity.
Recent News Highlights:
SCYNEXIS has been reaffirmed a 'Buy' rating due to strong financials and promising pipeline prospects.
The 'Buy' rating was also reaffirmed based on the success of Ibrexafungerp and a strong partnership with GSK.
Key Price Levels to Watch:
Monitor the resistance levels at $1.70, $1.85, and $2.00. Breaking these levels could indicate a potential upward movement. Consider taking partial profits at these levels to secure gains.
Stop Loss (SL): Set below $1.30 to minimize risk.
Take Profit (TP): Target approximately $2.15.
Additional information can be found in the accompanying chart.
Please trade with caution.
Disclaimer: This is not financial advice.
Upcoming Event: Preclinical Data Release on 04/24/2024
This is a highly speculative investment opportunity.
Recent News Highlights:
SCYNEXIS has been reaffirmed a 'Buy' rating due to strong financials and promising pipeline prospects.
The 'Buy' rating was also reaffirmed based on the success of Ibrexafungerp and a strong partnership with GSK.
Key Price Levels to Watch:
Monitor the resistance levels at $1.70, $1.85, and $2.00. Breaking these levels could indicate a potential upward movement. Consider taking partial profits at these levels to secure gains.
Stop Loss (SL): Set below $1.30 to minimize risk.
Take Profit (TP): Target approximately $2.15.
Additional information can be found in the accompanying chart.
Please trade with caution.
Commentaire
hit 1.95 todayTrade fermée: cible de profit atteinte
wow hit 2.9
Join Discord channel:
whop.com/marketplace/contingent-traders/
contingenttrader.com/
whop.com/marketplace/contingent-traders/
contingenttrader.com/
Clause de non-responsabilité
Les informations et les publications ne sont pas destinées à être, et ne constituent pas, des conseils ou des recommandations en matière de finance, d'investissement, de trading ou d'autres types de conseils fournis ou approuvés par TradingView. Pour en savoir plus, consultez les Conditions d'utilisation.